Valuation: IRADIMED CORPORATION

Market Cap 1.29B 1.13B 1.04B 967M 1.83B 123B 1.86B 12.45B 4.84B 60.41B 4.84B 4.74B 208B P/E 2026 *
52.9x
P/E 2027 * 46.6x
Enterprise Value 1.29B 1.13B 1.04B 967M 1.83B 123B 1.86B 12.45B 4.84B 60.41B 4.84B 4.74B 208B EV / Sales 2026 *
14.2x
EV / Sales 2027 * 12.8x
Free-Float
64.8%
Yield 2026 *
-
Yield 2027 * -
1 day+2.99%
1 week+7.46%
Current month+5.66%
1 month+7.91%
3 months+4.93%
6 months+5.73%
Current year+3.79%
1 week 92.68
Extreme 92.68
101.13
1 month 89.69
Extreme 89.69
101.13
Current year 76.95
Extreme 76.95
107.9
1 year 55.11
Extreme 55.1093
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 27/05/2020
Director of Finance/CFO 64 19/06/2022
Chief Tech/Sci/R&D Officer - 31/12/2019
Director TitleAgeSince
Director/Board Member 73 31/12/2013
Director/Board Member 61 01/09/2025
Director/Board Member 70 31/12/2018
Date Insider Type Main position Quantity % Market Cap.
06-19Fiscal year

Chief Financial Officer

13,911 0.1088%
06-03Sell

Director

-3,000 0.0235%
05-31Sell

Chief Executive Officer

-2,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
+2.99%+7.46%+63.38%+110.88% 1.29B
+1.01%+6.82%-17.00%-25.04% 12.68B
-0.64%+12.90%+96.73%+14.47% 5.2B
+1.56%+8.79%-31.06%-63.11% 1.24B
+0.09%+7.43%-37.06%-47.02% 1.12B
+2.72%+6.36%-43.18% - 928M
-1.88%+5.93%+166.25%+151.12% 637M
-1.22%-3.19%+65.45% - 364M
+0.59%+5.96%-52.58%+227.58% 268M
-0.24%-0.95%-26.22%-44.11% 139M
Average +0.50%+3.51%+18.47%+40.60% 2.39B
Weighted average by Cap. +0.69%+4.02%+15.12%-3.51%

Financials

2026 *2027 *
Net sales 91.2M 79.73M 73.27M 68.3M 130M 8.68B 132M 880M 342M 4.27B 342M 335M 14.71B 101M 88.21M 81.06M 75.56M 143M 9.61B 145M 973M 378M 4.72B 379M 371M 16.27B
Net income 24.55M 21.46M 19.72M 18.38M 34.87M 2.34B 35.4M 237M 92.05M 1.15B 92.15M 90.17M 3.96B 27.8M 24.3M 22.33M 20.82M 39.49M 2.65B 40.08M 268M 104M 1.3B 104M 102M 4.48B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
02/07/26 US$100.97 +2.99% 130,062
01/07/26 US$98.04 +2.60% 154,909
30/06/26 US$95.56 +1.58% 109,602
29/06/26 US$94.07 +0.12% 104,749
26/06/26 US$93.96 +0.10% 322,740
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
100.97USD
Average target price
118.00USD
Spread / Average Target
+16.87%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock